Fingerprint
Dive into the research topics of 'Phase 1 study of edasalonexent (CAT-1004), an oral NF-κ B inhibitor, in pediatric patients with duchenne muscular dystrophy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 1 study of edasalonexent (CAT-1004), an oral NF-κ B inhibitor, in pediatric patients with duchenne muscular dystrophy
Erika Finanger, Krista Vandenborne, Richard S. Finkel, H. Lee Sweeney, Gihan Tennekoon, Sabrina Yum, Maria Mancini, Pradeep Bista, Andrew Nichols, Hanlan Liu, Angelika Fretzen, Joanne M. Donovan
Research output: Contribution to journal › Article › peer-review
37
Scopus
citations